TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
St1 Biokraft AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
3,569
|
40,179
|
32,953 |
| Financial expenses |
8,519
|
10,440
|
5,301 |
| Earnings before taxes |
-36,811
|
-15,533
|
-8,570 |
| EBITDA |
-5,415
|
2,018
|
1,688 |
| Total assets |
168,976
|
176,786
|
168,411 |
| Current assets |
18,504
|
39,919
|
58,354 |
| Current liabilities |
31,515
|
31,676
|
23,146 |
| Equity capital |
62,778
|
52,265
|
66,753 |
| - share capital |
7,588
|
7,855
|
7,832 |
| Employees (average) |
45
|
115
|
105 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
37.2%
|
29.6%
|
39.6% |
| Turnover per employee |
79
|
349
|
314 |
| Profit as a percentage of turnover |
-1031.4%
|
-38.7%
|
-26.0% |
| Return on assets (ROA) |
-16.7%
|
-2.9%
|
-1.9% |
| Current ratio |
58.7%
|
126.0%
|
252.1% |
| Return on equity (ROE) |
-58.6%
|
-29.7%
|
-12.8% |
| Change turnover | |||
| Change turnover % |
22%
|
-7% | |
| Chg. No. of employees | |||
| Chg. No. of employees % |
10%
|
-4% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.